Dose Range Finding Study of Fedovapagon in Men With Nocturia

Status:
Completed

Trial end date:
2013-09-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the dose level(s) of fedovapagon which result in a decrease in the mean nocturnal void frequency.

Phase 2

Vantia Ltd